| Breakdown | TTM | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Jul 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.61B | 4.65B | 4.24B | 3.87B | 3.50B | 2.69B |
| Gross Profit | 2.09B | 2.10B | 1.91B | 1.74B | 1.61B | 1.34B |
| EBITDA | 1.96B | 2.11B | 1.76B | 1.65B | 1.51B | 1.26B |
| Net Income | 1.56B | 1.55B | 1.36B | 1.24B | 1.09B | 936.50M |
Balance Sheet | ||||||
| Total Assets | 10.59B | 10.09B | 8.43B | 6.74B | 5.31B | 4.56B |
| Cash, Cash Equivalents and Short-Term Investments | 5.10B | 4.79B | 3.42B | 2.36B | 1.38B | 1.05B |
| Total Debt | 96.14M | 103.74M | 118.73M | 120.45M | 119.47M | 518.07M |
| Total Liabilities | 787.73M | 883.41M | 879.21M | 750.44M | 683.26M | 1.03B |
| Stockholders Equity | 9.79B | 9.19B | 7.52B | 5.99B | 4.63B | 3.53B |
Cash Flow | ||||||
| Free Cash Flow | 1.41B | 1.23B | 961.57M | 847.57M | 839.24M | 527.89M |
| Operating Cash Flow | 1.80B | 1.80B | 1.47B | 1.36B | 1.18B | 990.89M |
| Investing Cash Flow | 143.66M | -587.45M | -940.08M | -1.89B | -442.31M | -465.47M |
| Financing Cash Flow | -190.98M | 52.11M | 19.27M | 66.61M | -382.69M | 40.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $11.08B | 11.90 | 16.56% | 3.14% | 2.25% | 8.92% | |
70 Outperform | $36.54B | 23.09 | 17.22% | ― | 6.69% | 13.94% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $6.47B | 14.74 | 7.46% | ― | 0.12% | 2.78% | |
60 Neutral | $1.15B | -15.68 | -16.33% | ― | 23.40% | 8.46% | |
58 Neutral | $7.12B | 11.79 | 27.05% | ― | 6.06% | -1.71% |
The current filing from Copart contains only a technical reference indicating that information disclosed under a different item of the same report is incorporated by reference, without providing operational, financial, or strategic details. As a result, the disclosure offers no substantive insight into Copart’s business activities, performance, or implications for shareholders and other stakeholders at this time.
The most recent analyst rating on (CPRT) stock is a Sell with a $33.00 price target. To see the full list of analyst forecasts on Copart stock, see the CPRT Stock Forecast page.
Copart, Inc. held its 2025 annual meeting of stockholders on December 5, 2025, where approximately 91% of the outstanding shares were represented. During the meeting, stockholders elected directors to serve until the 2026 annual meeting, approved executive compensation for the year ended July 31, 2025, and ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending July 31, 2026.
The most recent analyst rating on (CPRT) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on Copart stock, see the CPRT Stock Forecast page.